Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 186
Filter
1.
Mol Psychiatry ; 17(5): 486-93, 2012 May.
Article in English | MEDLINE | ID: mdl-22290118

ABSTRACT

In 1983, reports of antibodies in subjects with major depressive disorder (MDD) to an as-yet uncharacterized infectious agent associated with meningoencephalitis in horses and sheep led to molecular cloning of the genome of a novel, negative-stranded neurotropic virus, Borna disease virus (BDV). This advance has enabled the development of new diagnostic assays, including in situ hybridization, PCR and serology based on recombinant proteins. Since these assays were first implemented in 1990, more than 80 studies have reported an association between BDV and a wide range of human illnesses that include MDD, bipolar disorder (BD), schizophrenia (SZ), anxiety disorder, chronic fatigue syndrome, multiple sclerosis, amyotrophic lateral sclerosis, dementia and glioblastoma multiforme. However, to date there has been no blinded case-control study of the epidemiology of BDV infection. Here, in a United States-based, multi-center, yoked case-control study with standardized methods for clinical assessment and blinded serological and molecular analysis, we report the absence of association of psychiatric illness with antibodies to BDV or with BDV nucleic acids in serially collected serum and white blood cell samples from 396 subjects, a study population comprised of 198 matched pairs of patients and healthy controls (52 SZ/control pairs, 66 BD/control pairs and 80 MDD/control pairs). Our results argue strongly against a role for BDV in the pathogenesis of these psychiatric disorders.


Subject(s)
Bipolar Disorder/virology , Borna disease virus/immunology , Depressive Disorder, Major/virology , Schizophrenia/virology , Adult , Aged , Antibodies, Viral/blood , Case-Control Studies , Female , Humans , Male , Middle Aged , Psychiatric Status Rating Scales , RNA, Viral/blood
2.
Psychol Med ; 42(4): 865-73, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21861951

ABSTRACT

BACKGROUND: One aim of personalized medicine is to determine which treatment is to be preferred for an individual patient, given all patient information available. Particularly in mental health, however, there is a lack of a single objective, reliable measure of outcome that is sensitive to crucial individual differences among patients. METHOD: We examined the feasibility of quantifying the total clinical value provided by a treatment (measured by both harms and benefits) in a single metric. An expert panel was asked to compare 100 pairs of patients, one from each treatment group, who had participated in a randomized clinical trial (RCT) involving interpersonal psychotherapy (IPT) and escitalopram, selecting the patient with the preferred outcome considering both benefits and harms. RESULTS: From these results, an integrated preference score (IPS) was derived, such that the differences between any two patients' IPSs would predict the clinicians' preferences. This IPS was then computed for all patients in the RCT. A second set of 100 pairs was rated by the panel. Their preferences were highly correlated with the IPS differences (r=0.84). Finally, the IPS was used as the outcome measure comparing IPT and escitalopram. The 95% confidence interval (CI) for the effect size comparing treatments indicated clinical equivalence of the treatments. CONCLUSIONS: A metric that combines benefits and harms of treatments could increase the value of RCTs by making clearer which treatments are preferable and, ultimately, for whom. Such methods result in more precise estimation of effect sizes, without increasing the required sample size.


Subject(s)
Models, Statistical , Outcome Assessment, Health Care/methods , Precision Medicine , Randomized Controlled Trials as Topic/statistics & numerical data , Adult , Antidepressive Agents, Second-Generation/therapeutic use , Citalopram/therapeutic use , Confidence Intervals , Data Interpretation, Statistical , Depressive Disorder/therapy , Female , Humans , Male , Middle Aged , Observer Variation , Outcome Assessment, Health Care/statistics & numerical data , Psychotherapy , Therapeutic Equivalency
3.
Psychol Med ; 41(9): 1939-49, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21276276

ABSTRACT

BACKGROUND: Numerous longitudinal studies have identified risk factors for the onset of most eating disorders (EDs). Identifying women at highest risk within a high-risk sample would allow for focusing of preventive resources and also suggests different etiologies. METHOD: A longitudinal cohort study over 3 years in a high-risk sample of 236 college-age women randomized to the control group of a prevention trial for EDs. Potential risk factors and interactions between risk factors were assessed using the methods developed previously. Main outcome measures were time to onset of a subthreshold or full ED. RESULTS: At the 3-year follow-up, 11.2% of participants had developed a full or partial ED. Seven of 88 potential risk factors could be classified as independent risk factors, seven as proxies, and two as overlapping factors. Critical comments about eating from teacher/coach/siblings and a history of depression were the most potent risk factors. The incidence for participants with either or both of these risk factors was 34.8% (16/46) compared to 4.2% (6/144) for participants without these risk factors, with a sensitivity of 0.75 and a specificity of 0.82. CONCLUSIONS: Targeting preventive interventions at women with high weight and shape concerns, a history of critical comments about eating weight and shape, and a history of depression may reduce the risk for EDs.


Subject(s)
Feeding and Eating Disorders/epidemiology , Adolescent , Adult , Body Image , Body Weight , California/epidemiology , Cohort Studies , Comorbidity , Depressive Disorder/epidemiology , Depressive Disorder/psychology , Feeding and Eating Disorders/psychology , Female , Follow-Up Studies , Humans , Incidence , Longitudinal Studies , Risk Factors , Sensitivity and Specificity , Young Adult
4.
Psychol Med ; 41(1): 151-62, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20380782

ABSTRACT

BACKGROUND: Although many studies suggest that, on average, depression-specific psychotherapy and antidepressant pharmacotherapy are efficacious, we know relatively little about which patients are more likely to respond to one versus the other. We sought to determine whether measures of spectrum psychopathology are useful in deciding which patients with unipolar depression should receive pharmacotherapy versus depression-specific psychotherapy. METHOD: A total of 318 adult out-patients with major depression were randomly assigned to escitalopram pharmacotherapy or interpersonal psychotherapy (IPT) at academic medical centers at Pittsburgh, Pennsylvania and Pisa, Italy. Our main focus was on predictors and moderators of time to remission on monotherapy at 12 weeks. RESULTS: Participants with higher scores on the need for medical reassurance factor of the Panic-Agoraphobic Spectrum Self-Report (PAS-SR) had more rapid remission with IPT and those with lower scores on the psychomotor activation factor of the Mood Spectrum Self-Report (MOODS-SR) experienced more rapid remission with selective serotonin reuptake inhibitor (SSRI) pharmacotherapy. Non-specific predictors of longer time to remission with monotherapy included several panic spectrum and mood spectrum factors and the Social Phobia Spectrum (SHY) total score. Higher baseline scores on the 17- and 25-item Hamilton Depression Rating Scales (HAMD-17 and HAMD-25) and the Work and Social Adjustment Scale (WSAS) also predicted a longer time to remission, whereas being married predicted a shorter time to remission. CONCLUSIONS: This exploratory study identified several non-specific predictors but few moderators of psychotherapy versus pharmacotherapy outcome. It offers useful indicators of the characteristics of patients that are generally difficult to treat, but only limited guidance as to who benefits from IPT versus SSRI pharmacotherapy.


Subject(s)
Citalopram/therapeutic use , Depressive Disorder, Major/therapy , Psychotherapy , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adult , Affect , Anxiety/psychology , Depressive Disorder, Major/drug therapy , Depressive Disorder, Major/psychology , Female , Humans , Male , Predictive Value of Tests , Proportional Hazards Models , Psychiatric Status Rating Scales , Psychological Tests , Remission Induction , Time Factors
5.
Acta Psychiatr Scand ; 122(5): 414-26, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20199491

ABSTRACT

OBJECTIVE: To determine whether late-onset schizophrenia (LOS, onset after age 40) should be considered a distinct subtype of schizophrenia. METHOD: Participants included 359 normal comparison subjects (NCs) and 854 schizophrenia out-patients age >40 (110 LOS, 744 early-onset schizophrenia or EOS). Assessments included standardized measures of psychopathology, neurocognition, and functioning. RESULTS: Early-onset schizophrenia and LOS groups differed from NCs on all measures of psychopathology and functioning, and most cognitive tests. Early-onset schizophrenia and LOS groups had similar education, severity of depressive, negative, and deficit symptoms, crystallized knowledge, and auditory working memory, but LOS patients included more women and married individuals, had less severe positive symptoms and general psychopathology, and better processing speed, abstraction, verbal memory, and everyday functioning, and were on lower antipsychotic doses. Most EOS-LOS differences remained significant after adjusting for age, gender, severity of negative or deficit symptoms, and duration of illness. CONCLUSION: Late-onset schizophrenia should be considered a subtype of schizophrenia.


Subject(s)
Schizophrenia/classification , Activities of Daily Living/psychology , Adult , Age Factors , Age of Onset , Aged , Analysis of Variance , Chi-Square Distribution , Cognition , Female , Humans , Linear Models , Male , Middle Aged , Psychiatric Status Rating Scales , Schizophrenia/diagnosis , Schizophrenia/epidemiology , Schizophrenic Psychology , Sex Factors
6.
Neurology ; 73(11): 843-6, 2009 Sep 15.
Article in English | MEDLINE | ID: mdl-19752450

ABSTRACT

OBJECTIVE: The diagnosis of psychogenic nonepileptic seizures (PNES) can be challenging. In the absence of a gold standard to verify the reliability of the diagnosis by EEG-video, we sought to assess the interrater reliability of the diagnosis using EEG-video recordings. METHODS: Patient samples consisted of 22 unselected consecutive patients who underwent EEG-video monitoring and had at least an episode recorded. Other test results and histories were not provided because the goal was to assess the reliability of the EEG-video. Data were sent to 22 reviewers, who were board-certified neurologists and practicing epileptologists at epilepsy centers. Choices were 1) PNES, 2) epilepsy, and 3) nonepileptic but not psychogenic ("physiologic") events. Interrater agreement was measured using a kappa coefficient for each diagnostic category. We used generalized kappa coefficients, which measure the overall level of between-method agreement beyond that which can be ascribed to chance. We also report category-specific kappa values. RESULTS: For the diagnosis of PNES, there was moderate agreement (kappa = 0.57, 95% confidence interval [CI] 0.39-0.76). For the diagnosis of epilepsy, there was substantial agreement (kappa = 0.69, 95% CI 0.51-0.86). For physiologic nonepileptic episodes, the agreement was low (kappa = 0.09, 95% CI 0.02-0.27). The overall kappa statistic across all 3 diagnostic categories was moderate at 0.56 (95% CI 0.41-0.73). CONCLUSIONS: Interrater reliability for the diagnosis of psychogenic nonepileptic seizures by EEG-video monitoring was only moderate. Although this may be related to limitations of the study (diagnosis based on EEG-video alone, artificial nature of the forced choice paradigm, single episode), it highlights the difficulties and subjective components inherent to this diagnosis.


Subject(s)
Electroencephalography/methods , Seizures/diagnosis , Video Recording , Humans , Seizures/etiology
7.
Psychol Med ; 38(10): 1465-74, 2008 Oct.
Article in English | MEDLINE | ID: mdl-17976250

ABSTRACT

BACKGROUND: This study examined healthcare services used by adults diagnosed with an eating disorder (ED) in a large health maintenance organization in the Pacific Northwest. METHOD: Electronic medical records were used to collect information on all out-patient and in-patient visits and medication dispenses, from 2002 to 2004, for adults aged 18-55 years who received an ED diagnosis during 2003. Healthcare services received the year prior to, and following, the receipt of an ED diagnosis were examined. Cases were matched to five comparison health plan members who had a health plan visit close to the date of the matched case's ED diagnosis. RESULTS: Incidence of EDs (0.32% of the 104,130 females, and 0.02% of the 93,628 males) was consistent with prior research employing treatment-based databases, though less than community-based samples. Most cases (50%) were first identified during a primary-care visit and psychiatric co-morbidity was high. Health services use was significantly elevated in all service sectors among those with an ED when compared with matched controls both in the year preceding and that following the receipt of the incident ED diagnosis. Contrary to expectations, healthcare utilization was found to be similarly high across the spectrum of EDs (anorexia nervosa, bulimia nervosa, and eating disorders not otherwise specified). CONCLUSIONS: The elevation in health service use among women both before and after diagnosis suggests that EDs merit identification and treatment efforts commensurate with other mental health disorders (e.g. depression) which have similar healthcare impact.


Subject(s)
Feeding and Eating Disorders/therapy , Health Services/statistics & numerical data , Adolescent , Adult , Anxiety Disorders/epidemiology , Anxiety Disorders/therapy , Comorbidity , Depressive Disorder/epidemiology , Depressive Disorder/therapy , Feeding and Eating Disorders/epidemiology , Female , Humans , Male , Middle Aged , Northwestern United States/epidemiology , Office Visits/statistics & numerical data , Primary Health Care/statistics & numerical data , Stress Disorders, Post-Traumatic/epidemiology , Stress Disorders, Post-Traumatic/therapy
8.
Mol Psychiatry ; 12(6): 544-55, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17353910

ABSTRACT

The s allele variant of the serotonin transporter gene (5-HTT) has recently been observed to moderate the relationship of stress to depression and anxiety. To date no study has considered interactive effects of 5-HTT genotype, stress and hypothalamic-pituitary-adrenal (HPA) function on cognition in healthy, older adults, which may reflect developmental, functional or neurodegenerative effects of the serotonin transporter polymorphism. We investigated whether 5-HTT genotype interacts with cumulative life stress and HPA-axis measures of waking and diurnal cortisol slope to impact cognition in 154 non-depressed, older adults. Structural images of hippocampal volume were acquired on a subsample of 56 participants. The 5-HTT s allele was associated with both significantly lower delayed recall and higher waking cortisol levels. Presence of the s allele interacted with higher waking cortisol to negatively impact memory. We also observed a significant interaction of higher waking cortisol and the s allele on lower hippocampal volume. Smaller hippocampi and higher cortisol were associated with lower delayed recall only in s allele carriers. No impact or interactions of cumulative life stress with 5-HTT or cortisol were observed. This is the first investigation to identify an association of the 5-HTT s allele with poorer memory function in older adults. The interactive effects of the s allele and waking cortisol levels on reduced hippocampal volume and lower memory suggest that the negative effect of the serotonin polymorphism on memory is mediated by the HPA axis. Further, given the significant association of the s allele with higher waking cortisol in our investigation, future studies may be needed to evaluate the impact of the serotonin transporter polymorphism on any neuropsychiatric or behavioral outcome which is influenced by HPA axis function in older adults.


Subject(s)
Aging/genetics , Cognition/physiology , Hippocampus/anatomy & histology , Hydrocortisone/blood , Memory/physiology , Serotonin Plasma Membrane Transport Proteins/genetics , Aged , Aged, 80 and over , Aging/metabolism , Female , Hippocampus/metabolism , Humans , Hypothalamo-Hypophyseal System/metabolism , Male , Middle Aged , Organ Size , Pituitary-Adrenal System/metabolism , Polymorphism, Genetic , Reference Values , Regression Analysis , Serotonin Plasma Membrane Transport Proteins/metabolism , Stress, Psychological/genetics , Stress, Psychological/metabolism
9.
J Geriatr Psychiatry Neurol ; 19(1): 32-5, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16449758

ABSTRACT

The current study used Department of Veteran's Affairs (VA) clinical records, State of California pesticide application records, spatial maps of distribution of Parkinson's disease patients, and pesticide applications to determine if there was evidence for "blow-in" of pesticides as a factor in explaining the prevalence of Central Valley Parkinson's disease. The results did not support the hypothesis of increasing prevalence of Parkinsonism attributable to wind drift.


Subject(s)
Agriculture , Air Pollutants/toxicity , Parkinson Disease/epidemiology , Parkinsonian Disorders/chemically induced , Parkinsonian Disorders/epidemiology , Pesticides/toxicity , Topography, Medical , Wind , Air Pollutants/analysis , California , Causality , Cross-Sectional Studies , Humans , Parkinson Disease/diagnosis , Parkinsonian Disorders/diagnosis , Pesticides/analysis , Risk , Statistics as Topic
10.
Neurology ; 65(4): 642-4, 2005 Aug 23.
Article in English | MEDLINE | ID: mdl-16116137

ABSTRACT

The authors investigated the relationship between obstructive sleep apnea/hypopnea (OSAH) and cognition in 36 older adults, 18 APOE epsilon4 carriers, and 18 non-carriers. Greater numbers of respiratory events negatively impacted memory function in epsilon4 carriers only. This is the first study to provide preliminary evidence for a negative interaction of APOE epsilon4 and OSAH on memory in older adults, which may have important implications for treating cognitive decline and delaying dementia onset.


Subject(s)
Apolipoproteins E/genetics , Genetic Predisposition to Disease/genetics , Heterozygote , Memory Disorders/genetics , Sleep Apnea Syndromes/complications , Sleep Apnea Syndromes/genetics , Aged , Apolipoprotein E4 , Brain/metabolism , Brain/physiopathology , Cognition Disorders/genetics , Cognition Disorders/physiopathology , DNA Mutational Analysis , Disease Progression , Female , Genetic Testing , Genetic Variation/genetics , Humans , Male , Memory Disorders/physiopathology , Memory Disorders/psychology , Middle Aged , Neuropsychological Tests , Oxidative Stress/genetics , Sleep Apnea Syndromes/physiopathology , Sleep Stages/genetics
11.
J Geriatr Psychiatry Neurol ; 17(1): 36-8, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15018696

ABSTRACT

The purpose of this study was to assess whether pharmacy database information from US Department of Veterans Affairs (VA) medical centers could be used to screen for areas of higher Parkinson's disease prevalence in patients exposed to pesticides. The authors used pharmacy data sets and compared the use of antiparkinsonian medications at 2 VA medical centers in California: one in Palo Alto, near the ocean, and one in Fresno, downwind from extensively farmed parts of the Central Valley. They found that patients at Fresno had higher odds ratios (1.5-1.8) for the use of Parkinson's disease medications than patients at Palo Alto. These data are consistent with the observations of prior epidemiologic studies and suggest that VA pharmacy databases can prioritize locations for further epidemiologic research. However, a thorough exploration of alternative explanations is needed to reach definitive conclusions regarding the findings suggested by this method.


Subject(s)
Antiparkinson Agents/therapeutic use , Databases as Topic/statistics & numerical data , Environmental Exposure/adverse effects , Hospital Information Systems/statistics & numerical data , Mass Screening/statistics & numerical data , Parkinson Disease, Secondary/chemically induced , Pesticides/toxicity , Pharmacy Service, Hospital/statistics & numerical data , Veterans/statistics & numerical data , California/epidemiology , Environmental Exposure/statistics & numerical data , Humans , Odds Ratio , Parkinson Disease, Secondary/drug therapy , Parkinson Disease, Secondary/epidemiology , Risk Assessment/statistics & numerical data
12.
Psychol Bull ; 127(6): 715-33, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11726068

ABSTRACT

B. Rind, P. Tromovitch, and R. Bauserman (1998) examined the long-term effects of childhood sexual abuse (CSA) by meta-analyzing studies of college students. The authors reported that effects "were neither pervasive nor typically intense" and that "men reacted much less negatively than women" (p. 22) and recommended value-neutral reconceptualization of the CSA construct. The current analysis revealed numerous problems in that study that minimized CSA-adjustment relations, including use of a healthy sample, an inclusive definition of CSA, failure to correct for statistical attenuation, and misreporting of original data. Rind et al.'s study's main conclusions were not supported by the original data. As such, attempts to use their study to argue that an individual has not been harmed by sexual abuse constitute a serious misapplication of its findings.


Subject(s)
Adaptation, Psychological , Child Abuse, Sexual/psychology , Social Adjustment , Terminology as Topic , Child , Data Interpretation, Statistical , Humans , Meta-Analysis as Topic , Research Design/standards , Sex Factors
13.
Arch Pediatr Adolesc Med ; 155(10): 1143-8, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11576010

ABSTRACT

BACKGROUND: We hypothesized that children's perceptions of more neighborhood hazards would be associated with less physical activity, less aerobic fitness, and a higher body mass index. OBJECTIVE: To examine the association between a hazardous neighborhood context and physical activity in children. METHODS: Fourth-grade students (n = 796) of diverse ethnic and economic backgrounds completed measures of neighborhood hazards, self-reported physical activity, physical fitness, height, and weight. Parents (n = 518) completed telephone interviews and provided data on their education level and occupation. RESULTS: As expected, children from families of lower socioeconomic status perceived significantly more neighborhood hazards. Contrary to our hypothesis, the perception of more hazards was significantly associated with more reported physical activity. This finding was not explained by school heterogeneity, alteration of the hazards measure, or differences in socioeconomic status. CONCLUSION: To further examine the relationship between neighborhood hazards and physical activity, we suggest that future studies include assessments of sedentary behavior, parental fear of violence, parental regulation of children's leisure activities, and cost and quality of available play areas and organized sports.


Subject(s)
Exercise , Physical Fitness , Residence Characteristics , Social Problems , Acculturation , Analysis of Variance , Body Mass Index , California , Child , Crime , Ethnicity/statistics & numerical data , Female , Humans , Male , Poverty Areas , Socioeconomic Factors , Statistics, Nonparametric
14.
J Geriatr Psychiatry Neurol ; 14(3): 115-9, 2001.
Article in English | MEDLINE | ID: mdl-11563433

ABSTRACT

We examined the effect of the apolipoprotein E (apo E) epsilon4 allele on the relationship between self-reported stress and mood in caregivers of patients with Alzheimer's disease. Eighty-six female subjects between the ages of 28 and 82 years who were community-dwelling AD patient caregivers participated in the study. A cross-sectional analysis of stress and mood was performed using the Revised Memory and Behavior Problem Checklist and the Geriatric Depression Scale. All subjects were evaluated for normal cognitive function (Mini-Mental Status Examination) and apo E genotype. The results indicated that increased levels of stress were associated with increased levels of depressive symptoms in nondemented caregivers with the epsilon4 allele. This relationship was not observed in caregivers without the epsilon4 allele. These results suggest that carriers of the epsilon4 allele may respond differently to psychological stress than do individuals without the epsilon4 allele.


Subject(s)
Alzheimer Disease , Apolipoproteins E/genetics , Caregivers/psychology , Depressive Disorder, Major/genetics , Stress, Psychological/genetics , Stress, Psychological/psychology , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Gene Frequency/genetics , Genetic Predisposition to Disease , Genotype , Humans , Male , Memory Disorders/diagnosis , Mental Disorders/diagnosis , Middle Aged , Neuropsychological Tests , Stress, Psychological/diagnosis
15.
J Dev Behav Pediatr ; 22(3): 179-84, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11437193

ABSTRACT

Previous attempts to reduce the effects of television advertising on children's purchase requests have had little success. Therefore, we tested the effects of a classroom intervention to reduce television, videotape, and video game use on children's toy purchase requests, in a school-based randomized controlled trial. Third- and fourth-grade children (mean age, 8.9 years) in two sociodemographically and scholastically matched public elementary schools were eligible to participate. Children in one randomly selected elementary school received an 18-lesson, 6-month classroom curriculum to reduce television, videotape, and video game use. In both schools, in September (before intervention) and April (after intervention) of a single school year, children and parents reported children's prior week's purchase requests for toys seen on television. After intervention, children in the intervention school were significantly less likely to report toy purchase requests than children in the control school, with adjusting for baseline purchase requests, gender, and age (odds ratio, 0.29; 95% confidence interval, 0.12-0.69). Among intervention school children, reductions in self-reported purchase requests were also associated with reductions in television viewing. There was no significant difference between schools in parent reports of children's requests for toy purchases. These findings suggest that reducing television viewing is a promising approach to reducing the influences of advertising on children's behavior.


Subject(s)
Advertising , Cognitive Behavioral Therapy , Play and Playthings , Television , Child , Female , Humans , Internal-External Control , Male , Motivation , Personality Assessment
16.
Am J Psychiatry ; 158(6): 848-56, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11384888

ABSTRACT

OBJECTIVE: The authors developed a methodological basis for investigating how risk factors work together. Better methods are needed for understanding the etiology of disorders, such as psychiatric syndromes, that presumably are the result of complex causal chains. METHOD: Approaches from psychology, epidemiology, clinical trials, and basic sciences were synthesized. RESULTS: The authors define conceptually and operationally five different clinically important ways in which two risk factors may work together to influence an outcome: as proxy, overlapping, and independent risk factors and as mediators and moderators. CONCLUSIONS: Classifying putative risk factors into these qualitatively different types can help identify high-risk individuals in need of preventive interventions and can help inform the content of such interventions. These methods may also help bridge the gaps between theory, the basic and clinical sciences, and clinical and policy applications and thus aid the search for early diagnoses and for highly effective preventive and treatment interventions.


Subject(s)
Mental Disorders/etiology , Risk Factors , Causality , Humans , Linear Models , Mental Disorders/prevention & control , Mental Disorders/therapy , Outcome Assessment, Health Care , Terminology as Topic
17.
Arch Gen Psychiatry ; 58(5): 494-501, 2001 May.
Article in English | MEDLINE | ID: mdl-11343530

ABSTRACT

BACKGROUND: Metastatic breast cancer carries with it considerable psychosocial morbidity. Studies have shown that some patients with metastatic breast cancer experience clinically significant anxiety and depression and traumatic stress symptoms. Supportive-expressive group psychotherapy was developed to help patients with cancer face and adjust to their existential concerns, express and manage disease-related emotions, increase social support, enhance relationships with family and physicians, and improve symptom control. METHODS: Of 125 women with metastatic breast cancer recruited into the study, 64 were randomized to the intervention and 61 to the control condition. Intervention women were offered 1 year of weekly supportive-expressive group therapy and educational materials. Control women received educational materials only. Participants were assessed at baseline and every 4 months during the first year. Data at baseline and from at least 1 assessment were collected from 102 participants during this 12-month period, and these participants compose the study population. RESULTS: Primary analyses based on all available data indicated that participants in the treatment condition showed a significantly greater decline in traumatic stress symptoms on the Impact of Event Scale (effect size, 0.25) compared with the control condition, but there was no difference in Profile of Mood States total mood disturbance. However, when the final assessment occurring within a year of death was removed, a secondary analysis showed a significantly greater decline in total mood disturbance (effect size, 0.25) and traumatic stress symptoms (effect size, 0.33) for the treatment condition compared with the control condition. CONCLUSION: Supportive-expressive therapy, with its emphasis on providing support and helping patients face and deal with their disease-related stress, can help reduce distress in patients with metastatic breast cancer.


Subject(s)
Breast Neoplasms/pathology , Breast Neoplasms/therapy , Mood Disorders/therapy , Psychotherapy, Group/methods , Stress Disorders, Post-Traumatic/therapy , Adaptation, Psychological , Adult , Aged , Breast Neoplasms/psychology , Comorbidity , Female , Humans , Middle Aged , Mood Disorders/epidemiology , Mood Disorders/psychology , Neoplasm Metastasis , Psychiatric Status Rating Scales/statistics & numerical data , Social Support , Stress Disorders, Post-Traumatic/epidemiology , Stress Disorders, Post-Traumatic/psychology , Stress, Psychological/epidemiology , Stress, Psychological/psychology , Stress, Psychological/therapy , Treatment Outcome
18.
Psychol Methods ; 6(1): 35-48, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11285811

ABSTRACT

Identifying subgroups of high-risk individuals can lead to the development of tailored interventions for those subgroups. This study compared two multivariate statistical methods (logistic regression and signal detection) and evaluated their ability to identify subgroups at risk. The methods identified similar risk predictors and had similar predictive accuracy in exploratory and validation samples. However, the 2 methods did not classify individuals into the same subgroups. Within subgroups, logistic regression identified individuals that were homogeneous in outcome but heterogeneous in risk predictors. In contrast, signal detection identified individuals that were homogeneous in both outcome and risk predictors. Because of the ability to identify homogeneous subgroups, signal detection may be more useful than logistic regression for designing distinct tailored interventions for subgroups of high-risk individuals.


Subject(s)
Logistic Models , Risk Assessment/methods , Signal Detection, Psychological , Adult , Cross-Sectional Studies , Data Interpretation, Statistical , Female , Follow-Up Studies , Hispanic or Latino/statistics & numerical data , Humans , Male , Middle Aged , Obesity/epidemiology , Risk Assessment/statistics & numerical data , White People/statistics & numerical data
19.
J Stud Alcohol ; 62(1): 62-73, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11271966

ABSTRACT

OBJECTIVE: Despite enthusiasm for the potential of matching patients to alcohol treatments to improve outcomes, consistent findings have not emerged. This review considers the extent to which methodological factors may account for the pattern of findings from research on Patient x Alcohol Treatment interactions. METHOD: We focused on 55 studies that compared more than one type of alcohol treatment and included formal statistical tests for interactions. We examined four predictors of the number of significant interactions found in the 55 studies: (1) the number of statistical tests for interactions conducted, (2) the average number of participants, (3) whether or not participants were randomized to treatment and (4) the proportion of tested interactions that were hypothesis- or rationale-driven, as opposed to exploratory. RESULTS: Only the number of statistical tests for interactions predicted the number of patient-treatment interactions identified per study (zero-order r = 0.47; r2 = 0.22). A substantial number of tests for interactions (43) was conducted, on average, per study. Only a minority of the studies (33%) included enough participants to have a reasonable probability (0.80) of identifying a medium-sized matching effect. CONCLUSIONS: Drawing general conclusions regarding matching patients to alcohol treatments is hampered because Type I error has contributed to the matches identified, studies in this area are often underpowered, and the combinations of patient and treatment variables that have been tested are few relative to the numerous possible combinations. To be productive, future research will need to focus on patients at the extremes of matching dimensions and on distinct treatments. (J Stud. Alcohol 62: 62-73, 2001)


Subject(s)
Alcoholism/rehabilitation , Health Care Rationing/statistics & numerical data , Patient Selection , Humans
20.
J Am Acad Child Adolesc Psychiatry ; 40(2): 137-46, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11214601

ABSTRACT

OBJECTIVE: To examine ratings and objective measures of attention-deficit/hyperactivity disorder (ADHD) symptoms to assess whether ADHD children with and without comorbid conditions have equally high levels of core symptoms and whether symptom profiles differ as a function of comorbidity and gender. METHOD: Four hundred ninety-eight children from the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA) were divided into comorbid groups based on the parent Diagnostic Interview Schedule for Children and assessed via parents' and teachers' Swanson, Nolan, and Pelham (SNAP) ratings and a continuous performance test (CPT). Comorbidity and gender effects were examined using analyses of covariance controlled for age and site. RESULTS: CPT inattention, impulsivity, and dyscontrol errors were high in all ADHD groups. Children with ADHD + oppositional defiant or conduct disorder were rated as more impulsive than inattentive, while children with ADHD + anxiety disorders (ANX) were relatively more inattentive than impulsive. Girls were less impaired than boys on most ratings and several CPT indices, particularly impulsivity, and girls with ADHD + ANX made fewer CPT impulsivity errors than girls with ADHD-only. CONCLUSIONS: Children with ADHD have high levels of core symptoms as measured by rating scales and CPT, irrespective of comorbidity. However, there are important differences in symptomatology as a function of comorbidity and gender.


Subject(s)
Anxiety Disorders/epidemiology , Attention Deficit and Disruptive Behavior Disorders/epidemiology , Analysis of Variance , Attention Deficit Disorder with Hyperactivity/epidemiology , Child , Comorbidity , Conduct Disorder/epidemiology , Female , Humans , Male , North America/epidemiology , Risk Factors , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...